Scout

Scout addresses a critical gap in the burgeoning digital health landscape: accessible and reliable diagnostic testing. The absence of comprehensive testing data significantly restricts the potential of at-home healthcare services offered by providers and organizations. Scout offers an integrated platform comprising a central hub, specialized test kits, and a user-friendly application, facilitating convenient at-home health testing. This innovative approach reduces development costs tenfold and lowers the per-test price threefold compared to existing solutions. Scout's patented technology meets stringent performance standards required for accurate medical diagnoses and seamlessly integrates with existing healthcare technology infrastructure. By democratizing diagnostic testing and enhancing the patient experience, Scout is positioned to disrupt the $33 billion diagnostic market. With $16 million in non-dilutive funding secured from the NIH and other institutions, Scout has significantly de-risked its platform. The company's pipeline includes a diverse range of tests catering to primary care (respiratory and sexual health), wellness (gut health), and chronic conditions (certain cancers). Having already obtained FDA authorization for its platform in clinical settings, Scout plans to launch its flagship Scout Hub in 2024, marking a significant step towards accessible and comprehensive at-home healthcare.